chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client was vaccinated with Moderna vaccines on April 1 and May 1* 2021.  Client developed Covid symptoms and tested positive on 7/16/2021.  Symptoms of Covid are mild. (fever x 1 day, runny nose, slight cough.)    Reported to VAERS because client was fully vaccinated and developed Covid.     *Client was not sure of exact dates of vaccines and states that they may be off by a day or two, but definitely a month between vaccines.
6/22 53-year-old male with pmhx of ESRD on HD (M,W,F), R renal transplant (2014), CML, and hypertension who presents to the ER from preop with abnormal labs.
2/26/21 at 9am developed severe pain all over my entire body and every joint and extreme fatigue. Each day got a little better but lasted 3 days. No headache or fever.
Received the diluent component alone without the powder portion; Received the diluent component alone without the powder portion; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 16th June 2021, the patient received Menveo. On 16th June 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the diluent component alone without the powder portion, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The healthcare professional did not have the patient information available. The reporter consent to follow up.
Sore throat, felt feverish, 6/17/2005 right wrist pain 6/19-21 Cough and slight wheeze 6/17 somewhat feverish, itchy red areas beginning on 6/19/2005, more intense pm 6/19 more intense pm 6/20 and early am 6/21 rash (urticarial) on trunk and thighs forearms not petechial.  few patches on face no mucous membrane swelling
syncope episode that lasted a few seconds; This spontaneous report as received from a physician via a company representative refers to a 21-year-old male patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  In July 2018, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, route of administration, lot # and expiration date were not reported) for prophylaxis.  On an unknown date, the patient had a syncope episode that lasted a few seconds. The symptoms remained for about 30 minutes. The patient was then released from a medical care after he was up on his feet. The patient was still alive. The patient did not pass away.  The outcome of the event and the relatedness between the event and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) were not reported.  Upon internal review, the event of syncope was considered to be medically significant.
got sick went to the ER; product dose omission; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION COMPLICATION (got sick went to the ER) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (got sick went to the ER) (seriousness criterion hospitalization) and PRODUCT DOSE OMISSION ISSUE (product dose omission). The patient was hospitalized for 15 days due to VACCINATION COMPLICATION. At the time of the report, VACCINATION COMPLICATION (got sick went to the ER) and PRODUCT DOSE OMISSION ISSUE (product dose omission) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, patient felt few days later she got sick went to the ER, and did some tests for her heart and it was fine. Then the patient went to another hospital and was admitted to the hospital, was given plasma, hospital made sure patient was stable and was discharged after 2 weeks. The patient's diagnosis was unknown for what was the problem that caused hospitalization.  Concomitant product use was not provided by the reporter.   Treatment information was not provided.  Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
No known adverse event. Moderna booster was administered mistakenly in place of second dose Pfizer for his primary series.
sick, in hospital for 5 days; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles 2.5 years ago still had numbness, severe pain and sometimes burning sensation all the time on Right side). Concurrent medical conditions included pain, numbness and burning sensation.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness (serious criteria hospitalization). On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 16-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media and described the hospitalization for 5 days. The patient received dose of Shingles vaccine and it made him/her sick. The patient was in hospital for 5 days.  The patient stated that doller 100.00 decided not get 2nd one.  The patient wouldn't wish this on worst enemy. The follow-up would not possible, as no contact, details were available.
My left arm, it's got sore for about 3 days went away; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). An 84-year-old patient of an unspecified gender received bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, Formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on an unspecified date (Lot Number: EW0167, Expiration date: unknown), as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, after the first dose of vaccination, the patient experienced left arm got sore for about 3 days went away. The clinical details of the event as follows: Patient had been doing very well all the time, first and second shot in, patient left arm, it is got sore for about 3 days went away and that is all patient had experienced. The patient outcome of the event was resolved on an unspecified date in 2021.  QR Comment: Reporter type could not be probed as the consumer was unwilling to share any further information, hence captured by default as Consumer or other non-health professional in tab.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a physician via two company representatives and from a practice manager (support services director) and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 26-JUL-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 micrograms/1 ml injection, lot # L044917, expiration date 12-NOV-2016 (dose, route and site of administration were not reported). The administered dose of vaccine was exposed to temperature excursion (date unspecified) lasting for 48 hours, with the lowest recorded temperature of 34 degrees Fahrenheit (1.111111111 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
A report was received from a health care professional on 6 November 2003 concerning a 71year old male vaccinee who received expired Fluvirin on 5 November 2003. On 5 November 2003 the vaccinee received expired vaccine. No adverse event had occurred at the time of this report. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Cross reference with: PJP200301007, PJP200301008,PJP200301010.
Pt recv vax on 10/28/98; on 1/6/99 pt exp myalgia, arthralgia & Guillian-Barre syndrome; tx=immune globulin
This spontaneous report as received from a Reimbursement OA Specialist, refers to a 32 year old patient of unknown gender. Information about the patient's medical history and concurrent conditions was not provided. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (administration route, lot number and expiration date were not provided). No concomitant therapies were reported. According to the reporter the patient was vaccinated outside of the indicated age range. The outcome of the event was unknown at the time of this report. This is one of several reports from the same reporter. Additional information has been requested.
pt stated that he had bells palsy symptoms the day after he received the vaccine.  Unable to smile with left side of face, slight eye droop.   Symptoms resolved in 24 hours.  He received 2nd dose 1/27/21 as he did not state he had a reaction when asked prior to receiving the dose.
FELT A LITTLE COLD; SLIGHT HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 07-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced felt a little cold. On 09-MAR-2021, the subject experienced slight headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt a little cold, and slight headache on 09-MAR-2021. This report was non-serious.
Inconsolable screaming so much that he coughed up a small amount of blood, 102 fever.
Left axillary and left lateral breast fullness and discomfort. Started on the day following the vaccine, and persists through the date of this report.  Several visits to her primary Internist.  Initially worked up as a mass.  Evaluated for possible association with her breast.  Eventually referred to a breast general surgeon for evaluation.
Pt received Proquad, Pentacel, Hep A, Hep B and PCV13 vaccines on Aug. 29, 2019 and pt broke out in a rash on Sept. 9, 2019. Pt did see Dr. and doctor wants a VAERS report filled out.
My father received his shot on March 13, 2021.  He drove to move home and on March 28th started having his right arm go numb but did not tell us.  He asked to go the ER March 29th at 6:45am saying his chest hurt and was having a hard time breathing, this has happened before since having Covid in September.  I called 911 after he became dizzy and could not walk.  While at the ER suffered a massive stroke that paralyzed him from his nose down over a course of 3 days.  His brain stem was affected and he lost the ability to swallow.  After being on a ventilator for 72 hours he was removed from it and died less then 30 mins later from drowning in his own saliva on April 1, 2021.
Almost 3 months to the date of second vaccine my left arm/shoulder became extremely sore. Within 24 hours the pain was 8/10. I went to the ER at on 6/30 and told them what I was experiencing. They did not comment on the post vaccination possibility. No labs or scans were taken. I was given Prednisone 20 MG and told to take 3 tabs daily x5 days which I did without relief. Self care has not resolved the intense pain. I just spoke with a patient of mine who described the same situation as mine which makes me believe even more that this is secondary to the Covid vaccination. I have an appt with a new PCP scheduled but cannot get in to be seen until almost 2 more weeks.
An investigator reported that an 8 month old male received a 3rd dose of Prevnar as a post-marketing safety study. Concomitant vaccines included a 3rd dose of Infanrix, Recombivax-HB and Hib-Titer vaccines. On 12/29/01, the pt expired. The coroner's office is investigating the death as SIDS; however, confirmation of dx is "still pending receipt of results from toxicology, pathology, etc". The investigator assessed SIDS (expected per local package insert) as "not related" to study vaccine.
pain at the injection site; This is a spontaneous report from a contactable Pharmacist. This Pharmacist reported similar events for two patients (parents). This is first of two reports.   A female patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVENAR 13, lot number and expiration date were unknown) via an unspecified route of on an unspecified date in 2018 at single dose for immunization. The patient's medical history and concomitant medications were not reported. The pharmacist reported that his parents came in to be vaccinated and they experienced the typical pain at the injection site. This event occurred a year ago on an unspecified date in 2018. The pharmacist stated it was typical to experience pain at the injection site. The outcome of the event was unknown.  Information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019432636 same reporter/drug/event, different patient
extreme fatigue, jitters, elevated heart rate; jitters; elevated heart rate/resting heart rate increased 15 points from baseline; tremulous feeling/tremor; heart palpitations; excitable; revved up; weak; like it would be if you received an epinephrine shot or used an asthma inhaler.; This spontaneous case was reported by a pharmacist and describes the occurrence of FATIGUE (extreme fatigue, jitters, elevated heart rate), NERVOUSNESS (jitters), HEART RATE INCREASED (elevated heart rate/resting heart rate increased 15 points from baseline), TREMOR (tremulous feeling/tremor) and PALPITATIONS (heart palpitations) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced FATIGUE (extreme fatigue, jitters, elevated heart rate), NERVOUSNESS (jitters), HEART RATE INCREASED (elevated heart rate/resting heart rate increased 15 points from baseline), TREMOR (tremulous feeling/tremor), PALPITATIONS (heart palpitations), AGITATION (excitable), PSYCHOMOTOR HYPERACTIVITY (revved up), ASTHENIA (weak) and FEELING ABNORMAL (like it would be if you received an epinephrine shot or used an asthma inhaler.). On 25-Jan-2021, FATIGUE (extreme fatigue, jitters, elevated heart rate), NERVOUSNESS (jitters), HEART RATE INCREASED (elevated heart rate/resting heart rate increased 15 points from baseline), TREMOR (tremulous feeling/tremor), PALPITATIONS (heart palpitations), AGITATION (excitable), PSYCHOMOTOR HYPERACTIVITY (revved up), ASTHENIA (weak) and FEELING ABNORMAL (like it would be if you received an epinephrine shot or used an asthma inhaler.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment and concomitant medication provided
ACHES; FEVER; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.The batch number was not reported. As per procedure, no follow-up will be requested for this case. Concomitant medications included ibuprofen.  On an unspecified date, the subject experienced aches, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches, fever, and headache. This report was non-serious.
When the shot was being administered, the person who gave me the shot squeezed my shoulder and put the needle in while still squeezing. When the needle was pulled out, I felt liquid run down my arm and the person who administered the shot wiped it up. I'm not sure if this is normal or if I was not given the complete dose of the shot. I want to know if I should get my second dose administered again just in case. It has been 4 hours since I got the shot and my only symptom so far is a sore shoulder.
HX of thrombocytopenia, hypertension, generalized anxiety disorder COPD c/o weakness, nonproductive cough and was admitted to hospital on 08/11/2021.   Patient was discharged on 8/14/2021
Client was vaccinated with Moderna on 4/21/2021. Client was then vaccinated with Pfizer on 5/18/2021.
This case was reported by a pharmacist via call center representative and described the occurrence of needle injury in a female patient who intended to vaccinate the patient with Shingrix (batch number 37KL2, expiry date 12th February 2021) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced needle injury. On an unknown date, the outcome of the needle injury was unknown. It was unknown if the reporter considered the needle injury to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not applicable. The reporter had a nursing student that was helping to administer vaccinations, she pricked her finger on the syringe that contained the adjuvant suspension. The product was not administered to a consumer.
LICHEN PLANUS/BLISTERS WITH EVERY MEAL; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced lichen planus/blisters with every meal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of lichen planus/blisters with every meal was not reported. This report was non-serious.
Headache, Sedation, Chills, Swelling @ injection site Narrative:   Other Relevant History:
3/27/21  1:05 AM  Fever 101.5 F  3/28/21 12:00 PM Large  4-5" red sore ring rash in left armpit
NUMBESS AND TINGLINGNESS ON FACE, HEAVE WEIGHT OR PRESSURE ON CHEST AREA AND ITCHY THROAT BEGAN AROUND 1 HOUR AFTER VACCINATION.  AT 9:30PM PATIENT TOOK 2 TABLETS OF 25MG BENADRYL TO RELIEVE SYMPTOMS. SCRATCHINESS AT THROAT DISAPPEARED AT BEDTIME.  NO REDNESS AT SITE OF INJECTION. TOOK ANOTHER 2 TABLETS OF 25MG BENADRYL NEXT MORNING AT 10AM AS PRECAUTION.
Uncomfortable Swollen lymph nodes; Tiredness; Injection site Pain; very slight throbbing at the top right side of my head.; This is a spontaneous report received from a contactable Consumer. The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Mar2021 09:30 (Lot number: EN6205) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 11Mar2021, outcome "unknown", described as "Uncomfortable Swollen lymph nodes"; FATIGUE (non-serious) with onset 11Mar2021, outcome "unknown", described as "Tiredness"; VACCINATION SITE PAIN (non-serious) with onset 11Mar2021, outcome "unknown", described as "Injection site Pain"; HEADACHE (non-serious) with onset 11Mar2021, outcome "unknown", described as "very slight throbbing at the top right side of my head.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, fatigue, vaccination site pain, headache. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021507350 Same patient  different drug/event
Redness at the injection site; COVID arm; Itching close to the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching close to the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching close to the injection site). On 30-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site pruritus and Vaccination site erythema, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (Itching close to the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Then on Saturday, January 30th and Sunday 31st it was a larger area of redness and itching.
Blister herpes off lip on cheek. Diagnosed as Shingles.   Treatment 1 gram 3x day for 7 days
Fever, Aches all over body, chills, fatigue, back muscle pain, loss of appetite, 2 1/2 days bedridden. Very much similar to flu symptoms.  Left arms swollen, deeply bruised 2 inches in diameter, painful to touch.  5 days couldn't lay on that arm.  8 days still feel injection area with mild discomfort.